TTrialPathMatch Me to Trials
← Back to trials
RecruitingMajor Depressive Disorder (MDD)

Mechanisms Of Orbitofrontal Stimulation in Depression

Eligible age

18–65 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The orbitofrontal cortex (OFC), a region involved in emotional regulation, decision making, and reward processing, is a key area linked to antidepressant response. This study tests whether noninvasive stimulation of the OFC using transcranial magnetic stimulation (TMS) can improve depressive symptoms. TMS uses magnetic fields generated by a coil placed next to the scalp to alter brain activity.

Sponsor: Subha Subramanian

You may qualify if…

  • ✓ Age 18-65 years
  • ✓ Must be able to read, speak and understand English
  • ✓ DSM-5 diagnosis of major depressive disorder, experiencing a moderate to severe depressive episode (Hamilton Depression Rating Scale score greater than or equal to 17 points)
  • ✓ Must be judged by study staff to be capable of completing the study procedures
  • ✓ Participants will be in stable outpatient treatment with no recent (within the past 30 days) hospitalizations or changes in their medication regimens

You may not qualify if…

  • ✕ DSM-5 moderate to severe substance use disorder within the past three months, based on Structured Clinical Interview for DSM-5
  • ✕ Conditions that might result in increased risks of side effects or complications from rTMS or MRI, including:
  • ✕ History of fainting spells of unknown or undetermined etiology that might constitute seizures
  • ✕ Diagnosis of epilepsy with the exception of a single seizure of benign etiology (e.g., febrile seizures) in the judgment of a board-certified neurologist
  • ✕ Current or past history of a neurological disorder, such as stroke, a progressive neurologic disease, or intracranial brain lesion(s); and history of previous neurosurgery or head trauma that resulted in residual neurologic impairment
  • ✕ Any unstable medical condition
  • ✕ Any metal in the brain or skull (excluding dental fillings) unless cleared by the responsible covering MD
  • ✕ Any devices which could be affected by TMS or MRI such as a pacemaker, medication pump, nerve stimulator, cochlear implant, TENS unit, ventriculo-peritoneal shunt unless cleared by the responsible covering MD

Where it's recruiting

Source: ClinicalTrials.gov · NCT07230990 · last updated 2026-05-14

Mechanisms Of Orbitofrontal Stimulation in Depression · TrialPath